GHRH analog is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-08-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
The Second World War occurred from 1939 to 1945 and is the only conflict in which nuclear weapons have been used; both Hiroshima and Nagasaki, in the Empire of Japan, were devastated by atomic bombs dropped by the United States. The main Axis powers were Nazi Germany, the Empire of Japan, and the Kingdom of Italy; while the United Kingdom, the United States, the Soviet Union and China were the "Big Four" Allied powers. Nazi Germany, led by Adolf Hitler, was responsible for genocides, most notably the Holocaust, which murdered demographics considered Untermensch by the Nazis. These included about six million Jews and about five million others, such as Slavs, Roma, homosexuals, and the physically and mentally disabled. The United States, the Soviet Union, and Canada deported and interned minority groups within their own borders and, largely because of the conflict, many ethnic Germans were later expelled from Eastern Europe. Japan was responsible for attacking neutral nations without a declaration of war, such as the attack on Pearl Harbor. It is also known for its brutal treatment and killing of Allied prisoners of war and the inhabitants of Asia. It also used Asians as forced laborers and was responsible for the Nanjing Massacre in which 250,000 civilians were brutally murdered by Japanese troops. Noncombatants suffered at least as badly as or worse than the combatants, and the distinction between combatants and noncombatants was often blurred by the belligerents of total war in both conflicts. The outcome of the war had a profound effect on the course of world history.
== Coups d'état == "...Thailand has experienced more coups d'état than any other country in contemporary history." according to The Washington Post. Since 1932, Thailand has had seven coup attempts and 12 successful coups (as of 2015).
=== Photographic records === For the benefit of the patient and the physician–surgeon, a photographic history of the entire rhinoplastic procedure is established; beginning at the pre-operative consultation, continuing during the surgical operation procedures, and concluding with the post-operative outcome. To record the "before-and-after" physiognomies of the nose and the face of the patient, the specific visual perspectives required are photographs of the nose viewed from the anteroposterior (front-to-back) perspective; the lateral view (profiles), the worm's-eye view (from below), the bird's-eye view (overhead), and three-quarter-profile views.
=== Shock === Methylene blue increases blood pressure in people with vasoplegic syndrome (redistributive shock). It does not improve delivery of oxygen to tissues or decrease mortality. Methylene blue has been used in calcium channel blocker toxicity as a possible rescue therapy for distributive shock unresponsive to first-line agents. Limited to case reports, a 2024 review found low-quality evidence that methylene blue may reduce short-term mortality, duration of the need for vasopressors, and length of hospital stay.
Until the collapse of the federal government in 1991, the organisational and administrative structure of Somalia's healthcare sector was overseen by the Ministry of Health. Regional medical officials enjoyed some authority, but healthcare was largely centralised. The socialist government of former President of Somalia Siad Barre had put an end to private medical practice in 1972. Much of the national budget was devoted to military expenditure, leaving few resources for healthcare, among other services. Somalia's public healthcare system was largely destroyed during the ensuing civil war. As with other previously nationalised sectors, informal providers have filled the vacuum and replaced the former government monopoly over healthcare, with access to facilities witnessing a significant increase. Many new healthcare centres, clinics, hospitals and pharmacies have in the process been established through home-grown Somali initiatives. The cost of medical consultations and treatment in these facilities is low, at US$5.72 per visit in health centres (with a population coverage of 95%), and US$1.89–3.97 per outpatient visit and US$7.83–13.95 per bed day in primary through tertiary hospitals. Comparing the 2005–2010 period with the half-decade just prior to the outbreak of the conflict (1985–1990), life expectancy actually increased from an average of 47 years for men and women to 48.2 years for men and 51 years for women.
Sources: en.wikipedia.org
Those who eat it have visions of fearful things. Magicians or those who wish to harm someone administer it in food or drink. This herb is medicinal and its seed is used as a remedy for gout, ground up and applied to the part affected." Christian Rätsch has said, "A mild dosage produces medicinal and healing effects, a moderate dosage produces aphrodisiac effects, and high dosages are used for shamanic purposes". Wade Davis, an ethnobotanist, also lists it as an essential ingredient of a zombie potion in Haitian Vodou. In Western culture, the same species (Datura stramonium) has been said to have been commonly used by witches as an ingredient for their flying ointments and was regularly included in detailed recipes of magical ointments dating back as far as the early modern period, predominately in New England and Western Europe. During the anti-witchcraft hysteria of colonial times it was considered unlucky or inappropriate to grow D. stramonium in one's garden due to its supposed reputation for aiding in incantations.
In 1913, Leonard Rowntree and John Jacob Abel of Johns Hopkins Hospital developed the first dialysis system which they successfully tested in animals. A Dutch doctor, Willem Johan Kolff, constructed the first working dialyzer in 1943 during the Nazi occupation of the Netherlands. Due to the scarcity of available resources, Kolff had to improvise and build the initial machine using sausage casings, beverage cans, a washing machine and various other items that were available at the time. Over the following two years (1944–1945), Kolff used his machine to treat 16 patients with acute kidney failure, but the results were unsuccessful. Then, in 1945, a 67-year-old comatose woman regained consciousness following 11 hours of hemodialysis with the dialyzer and lived for another seven years before dying from an unrelated condition. She was the first-ever patient successfully treated with dialysis. Gordon Murray of the University of Toronto independently developed a dialysis machine in 1945. Unlike Kolff's rotating drum, Murray's machine used fixed flat plates, more like modern designs. Like Kolff, Murray's initial success was in patients with acute renal failure. Nils Alwall of Lund University in Sweden modified a similar construction to the Kolff dialysis machine by enclosing it inside a stainless steel canister. This allowed the removal of fluids, by applying a negative pressure to the outside canister, thus making it the first truly practical device for hemodialysis. Alwall treated his first patient in acute kidney failure on 3 September 1946.
Matlock is an American legal drama television series that premiered with a sneak peek on September 22, 2024, before its timeslot premiere on October 17 on CBS. The show was developed by Jennie Snyder Urman, and while it shares a name with the Matlock TV series which starred Andy Griffith, it features a vastly different premise overall. In October 2024, the series was renewed for a second season which premiered on October 12, 2025. In January 2026, the series was renewed for a third season.
== Nutritional profile == Sirloin steak is a nutrient-dense source of protein and contains essential micronutrients. A 100 g serving of cooked sirloin steak typically provides 200-313 kilocalories. It contains 28-30 g of protein, 0 g of carbohydrates and 9-21 g of fat, depending on the cooking method and trimming. The cut is generally leaner than heavily marbled steaks, such as ribeye, which results in a lower total fat content. A 100 g sirloin steak also contains 2–3 mg of iron and 3 mg of vitamin B12. These vitamins are important for oxygen transport and neurological function.
Sources: en.wikipedia.org
A replica of the San Juan Bautista was reconstructed in 1993 on the basis of the records of the House of Date. Although its blueprints have not been found, the ship's dimensions were recorded properly, permitting a speculative reconstitution. The ship was put on display in the Miyagi Sant Juan Bautista Museum in Ishinomaki, in northern Japan, close to the location where she was originally built. The replica survived the 2011 Tōhoku earthquake and tsunami with some damage, and there were hopes in 2011 of using the ship as a symbol of the town's reconstruction. In November 2013 the repaired San Juan Bautista was rededicated. Assistance had come from Western Forest Products, a British Columbia lumber company, who supplied the massive Douglas fir and cedar logs to create masts that had been damaged in the tsunami. However, the replica ship was deemed to be unsafe to the public due to structural damage from floodwater and other factors, and the Miyagi prefectural government decided to demolish the ship rather than to continue repairing it. Dismantling began in November 2021. The government built a new ship in its place, using fibre-reinforced plastic and reducing the size to one quarter of the original. The new, smaller ship was revealed to the public in October 2024.
== Treatment == The most important measure is prevention – avoidance of the drugs and foods that cause hemolysis. Vaccination against some common pathogens (e.g. hepatitis A and hepatitis B) may prevent infection-induced attacks. In the acute phase of hemolysis, blood transfusions might be necessary, or even dialysis in acute kidney failure. Blood transfusion is an important symptomatic measure, as the transfused red cells are generally not G6PD deficient and will live a normal lifespan in the recipient's circulation. Those affected should avoid drugs such as aspirin. Some patients may benefit from the removal of the spleen (splenectomy), as this is an important site of red cell destruction. Folic acid should be used in any disorder featuring a high red cell turnover. Although vitamin E and selenium have antioxidant properties, their use does not decrease the severity of G6PD deficiency. AG1, a recently discovered small molecule, has been shown to increase the activity of the G6PD enzyme in the three common variants of the deficiency. Due to the absence of medications to treat G6PD, AG1 is a promising precursor in developing a pharmacological treatment effective for multiple G6PD enzymopathies.
=== Additional effects === Semaglutide typically causes a benign increase in resting heart rate (around 3 beats per minute), which has not been associated with adverse cardiovascular events. In January 2026, the US Food and Drug Administration requested removal of suicidal behavior and ideation warning from glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. A 2024 systematic review of 6 studies found that while lean body mass was unchanged in some cases, there were instances of significant decreases in lean body mass (0–40%). However, the review concluded that in all studies the ratio of lean body mass to total body mass increased, supporting continued use of the medication. After stopping semaglutide, individuals on average regain 67% of the weight they lost during treatment within the following year, according to a 2025 systematic review. People return to their previous weight within a year and a half on average after stopping semaglutide.
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.